Xinyuan shares: it is proposed to launch the restricted stock incentive plan in 2022

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

China Embodied AI Data Platform Maniformer Raises Hundreds of Mns RMB,Led by Sequoia China

Recently, China embodied AI data platform Maniformer (觅蜂科技) announced the completion of several hundred million RMB in seed and angel financing.

RoboScience Raises Several Hundred Million RMB in Pre-A Round to Advance VLOA Model

“The Scaling Law is a prerequisite for embodied intelligence to achieve true large-scale commercial deployment, and it is also key to breaking through the industry’s development bottlenecks,” said Kun Xu, Business Partner of the Investment Banking Division at China Renaissance.

GrainCore Dynamics Raises Two Rounds in 90 Days, Backed by Tsinghua & HIT

Focused on drones and five categories of agricultural robots—crop protection, inspection, harvesting, weeding, and transport—now deployed in pilot farms across China, the Middle East, South America, and Africa.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.